Project Grant HT94252411059
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The U.S. Defense Health Agency awarded a $1,489,045 project grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research aims to investigate medical solutions for battlefield and other neurotrauma-related vision impairments. This 4-year award,...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under CFDA Program 12.420 - Military Medical Research and Development. The $1,479,970.00 award to The Ohio State University, with a performance period from July 15, 2025 to July 14, 2029, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on innovative...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,465,907 award, made on Jul 15, 2025, supports advanced biomedical research at The Ohio State University (OSU) aimed at transforming healthcare for military service members, veterans, and the broader public. The project will focus on innovative research to address critical health...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
This federal Project Grant award for $7,700,740.00 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The funding supports a 4-year research project titled "CONSEQUENCES OF BRAIN INJURY ON GLIA-NEURON DYNAMICS, NEUROPATHOLOGY, AND NEUROPSYCHIATRIC ILLNESS" aimed at investigating the effects of brain injury on glial-neuronal interactions, neuropathology, and neuropsychiatric conditions. The...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
The Department of the Army Medical Command awarded a $755,250 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development federal grant program. The three-year award beginning September 30, 2022 will fund research to define the genetic basis and pathologic network of post-traumatic epilepsy using Collaborative Cross mice. As part of the Military Medical Research and Development program's goals to transform military and public...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...